“activated-cell-therapy” Archives

in
Entry Author Date Location
Dendreon’s Warhorse, Chief Scientific Officer Dave Urdal, To Retire at Year-End 03/11/11 Seattle
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 1 07/27/09 Seattle
Page 1 of 1